IRAK4 inhibitor-1 is a novel and potent inhibitor of Interleukin-1 receptor-associated kinase 4 (IRAK4) which is the most upstream kinase in Toll/Interleukin-1 receptor (TIR) signaling pathway. IRAK4 inhibitors have the therapeutic potential for treating autoimmune disease (e.g. rheumatoid arthritis- RA) and cancer.

纯度：≥98%

CAS：1801344-12-6